<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="7093748S2214-2509(19)30306-3 doi: 10.1016/j.idcr.2019.e00667e00667 : Article A fatal case of severe" exact="systemic" post="varicella zoster infection in a patient with chronic use"/>
 <result pre="doi: 10.1016/j.idcr.2019.e00667e00667 : Article A fatal case of severe systemic" exact="varicella" post="zoster infection in a patient with chronic use of"/>
 <result pre="10.1016/j.idcr.2019.e00667e00667 : Article A fatal case of severe systemic varicella" exact="zoster" post="infection in a patient with chronic use of immunosuppressive"/>
 <result pre=": Article A fatal case of severe systemic varicella zoster" exact="infection" post="in a patient with chronic use of immunosuppressive agents"/>
 <result pre="of severe systemic varicella zoster infection in a patient with" exact="chronic" post="use of immunosuppressive agents for cutaneous vasculitis LinWei-ChenaChangChingaKoMeng-ChengbLinShu-Minsmlin100@gmail.combc⁎[a], [b],"/>
 <result pre="in a patient with chronic use of immunosuppressive agents for" exact="cutaneous" post="vasculitis LinWei-ChenaChangChingaKoMeng-ChengbLinShu-Minsmlin100@gmail.combc⁎[a], [b], [c], ⁎Corresponding author at: Department of"/>
 <result pre="a patient with chronic use of immunosuppressive agents for cutaneous" exact="vasculitis" post="LinWei-ChenaChangChingaKoMeng-ChengbLinShu-Minsmlin100@gmail.combc⁎[a], [b], [c], ⁎Corresponding author at: Department of Thoracic"/>
 <result pre="cutaneous vasculitis LinWei-ChenaChangChingaKoMeng-ChengbLinShu-Minsmlin100@gmail.combc⁎[a], [b], [c], ⁎Corresponding author at: Department of" exact="Thoracic" post="Medicine, Chang Gung Memorial Hospital, 199 Tun-Hwa N. Rd.,"/>
 <result pre="access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Highlights •Varicella" exact="zoster" post="virus infection can cause severe complication in immunocompromised patients."/>
 <result pre="article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Highlights •Varicella zoster" exact="virus infection" post="can cause severe complication in immunocompromised patients. •Early parenteral"/>
 <result pre="under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Highlights •Varicella zoster virus" exact="infection" post="can cause severe complication in immunocompromised patients. •Early parenteral"/>
 <result pre="parenteral antiviral therapy is mandatory for preventing severe complication of" exact="varicella" post="zoster virus infection. •Post exposure prophylaxis varicella zoster immunoglobulin"/>
 <result pre="antiviral therapy is mandatory for preventing severe complication of varicella" exact="zoster" post="virus infection. •Post exposure prophylaxis varicella zoster immunoglobulin is"/>
 <result pre="therapy is mandatory for preventing severe complication of varicella zoster" exact="virus infection." post="•Post exposure prophylaxis varicella zoster immunoglobulin is beneficial for"/>
 <result pre="severe complication of varicella zoster virus infection. •Post exposure prophylaxis" exact="varicella" post="zoster immunoglobulin is beneficial for immunocompromised patients. Abstract Acute"/>
 <result pre="complication of varicella zoster virus infection. •Post exposure prophylaxis varicella" exact="zoster" post="immunoglobulin is beneficial for immunocompromised patients. Abstract Acute varicella"/>
 <result pre="prophylaxis varicella zoster immunoglobulin is beneficial for immunocompromised patients. Abstract" exact="Acute" post="varicella zoster virus (VZV) infection is a common condition"/>
 <result pre="varicella zoster immunoglobulin is beneficial for immunocompromised patients. Abstract Acute" exact="varicella" post="zoster virus (VZV) infection is a common condition in"/>
 <result pre="zoster immunoglobulin is beneficial for immunocompromised patients. Abstract Acute varicella" exact="zoster" post="virus (VZV) infection is a common condition in children,"/>
 <result pre="beneficial for immunocompromised patients. Abstract Acute varicella zoster virus (VZV)" exact="infection" post="is a common condition in children, which is considered"/>
 <result pre="common condition in children, which is considered a mild, self-limited" exact="disease" post="with diffuse skin vesicular rash. However, disseminated VZV infection"/>
 <result pre="in children, which is considered a mild, self-limited disease with" exact="diffuse" post="skin vesicular rash. However, disseminated VZV infection with multiple"/>
 <result pre="self-limited disease with diffuse skin vesicular rash. However, disseminated VZV" exact="infection" post="with multiple organ involvement can occur in immunocompromised patients"/>
 <result pre="stem cell transplant recipients, receiving immunosuppressive therapy, leukemia, lymphoma, and" exact="HIV infection." post="Prompt antiviral therapy is mandatory in those immunocompromised persons."/>
 <result pre="mandatory in those immunocompromised persons. A 52 year-old man receiving" exact="chronic" post="immunosuppressive drugs for his underlying leukocytoclastic vasculitis visited emergency"/>
 <result pre="year-old man receiving chronic immunosuppressive drugs for his underlying leukocytoclastic" exact="vasculitis" post="visited emergency department for diffuse skin vesicular rash that"/>
 <result pre="drugs for his underlying leukocytoclastic vasculitis visited emergency department for" exact="diffuse" post="skin vesicular rash that developed 4 days after contact"/>
 <result pre="skin vesicular rash that developed 4 days after contact with" exact="varicella" post="zoster patients at his office. Despite prompt initiation of"/>
 <result pre="vesicular rash that developed 4 days after contact with varicella" exact="zoster" post="patients at his office. Despite prompt initiation of oral"/>
 <result pre="of oral antiviral agents had been prescribed, rapid progression with" exact="septic shock," post="lactate acidosis, and disseminated intravascular coagulopathy occurred. The patient"/>
 <result pre="rapid progression with septic shock, lactate acidosis, and disseminated intravascular" exact="coagulopathy" post="occurred. The patient died within 24 h of intensive care"/>
 <result pre="The patient died within 24 h of intensive care unit admission." exact="Varicella" post="zoster infection commonly causes severe complications in adults receiving"/>
 <result pre="patient died within 24 h of intensive care unit admission. Varicella" exact="zoster" post="infection commonly causes severe complications in adults receiving chronic"/>
 <result pre="died within 24 h of intensive care unit admission. Varicella zoster" exact="infection" post="commonly causes severe complications in adults receiving chronic immunosuppressive"/>
 <result pre="Varicella zoster infection commonly causes severe complications in adults receiving" exact="chronic" post="immunosuppressive therapy. Post exposure prophylaxis varicella zoster immune globulin"/>
 <result pre="complications in adults receiving chronic immunosuppressive therapy. Post exposure prophylaxis" exact="varicella" post="zoster immune globulin and early parenteral antiviral agents use"/>
 <result pre="in adults receiving chronic immunosuppressive therapy. Post exposure prophylaxis varicella" exact="zoster" post="immune globulin and early parenteral antiviral agents use after"/>
 <result pre="zoster immune globulin and early parenteral antiviral agents use after" exact="acute" post="varicella virus infection may be mandatory in immunocompromised patients."/>
 <result pre="immune globulin and early parenteral antiviral agents use after acute" exact="varicella" post="virus infection may be mandatory in immunocompromised patients. Keywords"/>
 <result pre="globulin and early parenteral antiviral agents use after acute varicella" exact="virus infection" post="may be mandatory in immunocompromised patients. Keywords Varicella zoster"/>
 <result pre="and early parenteral antiviral agents use after acute varicella virus" exact="infection" post="may be mandatory in immunocompromised patients. Keywords Varicella zoster"/>
 <result pre="varicella virus infection may be mandatory in immunocompromised patients. Keywords" exact="Varicella" post="zoster Systemic infection Mortality Vasculitis Immunosuppressive agents Background Immunosuppressive"/>
 <result pre="virus infection may be mandatory in immunocompromised patients. Keywords Varicella" exact="zoster" post="Systemic infection Mortality Vasculitis Immunosuppressive agents Background Immunosuppressive drugs"/>
 <result pre="infection may be mandatory in immunocompromised patients. Keywords Varicella zoster" exact="Systemic" post="infection Mortality Vasculitis Immunosuppressive agents Background Immunosuppressive drugs and"/>
 <result pre="may be mandatory in immunocompromised patients. Keywords Varicella zoster Systemic" exact="infection" post="Mortality Vasculitis Immunosuppressive agents Background Immunosuppressive drugs and disease"/>
 <result pre="mandatory in immunocompromised patients. Keywords Varicella zoster Systemic infection Mortality" exact="Vasculitis" post="Immunosuppressive agents Background Immunosuppressive drugs and disease modifying antirheumatic"/>
 <result pre="Systemic infection Mortality Vasculitis Immunosuppressive agents Background Immunosuppressive drugs and" exact="disease" post="modifying antirheumatic medicines are widely used in the treatment"/>
 <result pre="modifying antirheumatic medicines are widely used in the treatment of" exact="connective tissue disease." post="However, usage of immunosuppressive medications is associated with increased"/>
 <result pre="of immunosuppressive medications is associated with increased risk of severe" exact="infection" post="[1]. Varicella zoster infection can be caused by primary"/>
 <result pre="medications is associated with increased risk of severe infection [1]." exact="Varicella" post="zoster infection can be caused by primary infection or"/>
 <result pre="is associated with increased risk of severe infection [1]. Varicella" exact="zoster" post="infection can be caused by primary infection or reactivation."/>
 <result pre="associated with increased risk of severe infection [1]. Varicella zoster" exact="infection" post="can be caused by primary infection or reactivation. Risk"/>
 <result pre="severe infection [1]. Varicella zoster infection can be caused by" exact="primary" post="infection or reactivation. Risk of reactivation is related to"/>
 <result pre="infection [1]. Varicella zoster infection can be caused by primary" exact="infection" post="or reactivation. Risk of reactivation is related to age-related"/>
 <result pre="related to age-related immune senescence or immunocompromised status. Complications include" exact="cutaneous" post="dissemination and serious visceral organ involvement such as severe"/>
 <result pre="dissemination and serious visceral organ involvement such as severe pneumonia," exact="hepatitis" post="and meningo-encephalitis. Post exposure varicella immune globulin and prompt"/>
 <result pre="involvement such as severe pneumonia, hepatitis and meningo-encephalitis. Post exposure" exact="varicella" post="immune globulin and prompt antiviral therapy may contribute to"/>
 <result pre="immune globulin and prompt antiviral therapy may contribute to decrease" exact="disease" post="progression in immunocompromised patients [2,3]. In this case report,"/>
 <result pre="this case report, we described a fulminant clinical course of" exact="varicella" post="zoster infection in a immunosuppressed host after contact with"/>
 <result pre="case report, we described a fulminant clinical course of varicella" exact="zoster" post="infection in a immunosuppressed host after contact with varicella"/>
 <result pre="report, we described a fulminant clinical course of varicella zoster" exact="infection" post="in a immunosuppressed host after contact with varicella zoster"/>
 <result pre="varicella zoster infection in a immunosuppressed host after contact with" exact="varicella" post="zoster patients. Case presentation A 52-year-old man visit emergency"/>
 <result pre="zoster infection in a immunosuppressed host after contact with varicella" exact="zoster" post="patients. Case presentation A 52-year-old man visit emergency department"/>
 <result pre="patients. Case presentation A 52-year-old man visit emergency department for" exact="diffuse" post="vesicular skin rash over the trunk for one day"/>
 <result pre="day (Fig. 1A) after contact with his co-workers diagnosed as" exact="varicella" post="infection 4 days before. He also had headache, sore"/>
 <result pre="(Fig. 1A) after contact with his co-workers diagnosed as varicella" exact="infection" post="4 days before. He also had headache, sore throat"/>
 <result pre="headache, sore throat and nausea. He denied prior history of" exact="chicken pox." post="He took immunosuppressants including methotrexate (12.5 mg per week), azathioprine"/>
 <result pre="per day) and prednisolone (10 mg per day) for his underlying" exact="cutaneous" post="leukocytoclastic vasculitis since 5 years ago. Vesicle Tzank smear"/>
 <result pre="and prednisolone (10 mg per day) for his underlying cutaneous leukocytoclastic" exact="vasculitis" post="since 5 years ago. Vesicle Tzank smear was performed."/>
 <result pre="performed. Multinucleated giant cells were found (Fig. 1B), which implied" exact="herpes" post="virus infection. Serum labratory examination showed: white blood cell"/>
 <result pre="Multinucleated giant cells were found (Fig. 1B), which implied herpes" exact="virus infection." post="Serum labratory examination showed: white blood cell count 4100/uL,"/>
 <result pre="(AST) 782 U/L ( ≤ 34), Alanine transaminase (ALT) 603 U/L (≤36)," exact="total" post="bilirubin 0.4 mg/dL, prothrombin time 12.6 s (10–13) and C reactive"/>
 <result pre="(10–13) and C reactive protein 1.45 mg/L. Under the impression of" exact="varicella" post="zoster complicated with hepatitis, oral famciclovir 500 mg three times"/>
 <result pre="and C reactive protein 1.45 mg/L. Under the impression of varicella" exact="zoster" post="complicated with hepatitis, oral famciclovir 500 mg three times per"/>
 <result pre="general malaise and nausea. Upon admission, his clinical status was" exact="acute" post="ill looking and alert (E4V5M6). Vital sign were: temperature"/>
 <result pre="were: temperature 36.2 °C, blood pressure 54/46 mmHg, pulse rate 102 beats/minute," exact="respiratory" post="rate 20 cycles/min. Blood labratory examination were: white blood"/>
 <result pre="pressure 54/46 mmHg, pulse rate 102 beats/minute, respiratory rate 20 cycles/min." exact="Blood" post="labratory examination were: white blood cell 12700/uL, hemoglobin 15.4 g/dL,"/>
 <result pre="12700/uL, hemoglobin 15.4 g/dL, and platelets 61000/uL, prothrombin time 35.7 s, actived" exact="partial" post="thrombin time 44.5 s (24–31), fibrinogen &amp;lt;50 mg/dL, AST 8989 U/L,"/>
 <result pre="44.5 s (24–31), fibrinogen &amp;lt;50 mg/dL, AST 8989 U/L, ALT 6048 U/L," exact="total" post="bilirubine 2.0 mg/dL, indirect total bilirubin 1.5 mg/dL and serum creatinine"/>
 <result pre="AST 8989 U/L, ALT 6048 U/L, total bilirubine 2.0 mg/dL, indirect" exact="total" post="bilirubin 1.5 mg/dL and serum creatinine 2.99 mg/dL. Blood arterial gas"/>
 <result pre="bilirubine 2.0 mg/dL, indirect total bilirubin 1.5 mg/dL and serum creatinine 2.99 mg/dL." exact="Blood" post="arterial gas analysis showed PH 7.31 CO2 23 mmHg O2"/>
 <result pre="cannula oxgen flow 5 L/min. Serum tests for possible causes of" exact="acute hepatitis" post="were all negative, including Hepatitis B surface antigen (HbsAg),"/>
 <result pre="oxgen flow 5 L/min. Serum tests for possible causes of acute" exact="hepatitis" post="were all negative, including Hepatitis B surface antigen (HbsAg),"/>
 <result pre="for possible causes of acute hepatitis were all negative, including" exact="Hepatitis" post="B surface antigen (HbsAg), antibodies against hepatitis C (anti-HCV),"/>
 <result pre="all negative, including Hepatitis B surface antigen (HbsAg), antibodies against" exact="hepatitis" post="C (anti-HCV), anti-hepatitis A immunoglobulin M (IgM) antibody, Epstein-Barr"/>
 <result pre="(anti-HCV), anti-hepatitis A immunoglobulin M (IgM) antibody, Epstein-Barr virus (EBV)" exact="viral" post="capsid antigen IgM and immunoglobulin G (IgG), serum Cytomegalovirus"/>
 <result pre="for VZV was positive during admission. Vesicular base and serum" exact="viral" post="isolation also yielded the growth of VZV thereafter. In"/>
 <result pre="He was admitted to an intensive care unit due to" exact="septic shock," post="multiple organ failure, and disseminated intravascular coagulopathy. He received"/>
 <result pre="empirical antibiotics including glycopeptide and carbapenem, blood transfusion for correcting" exact="anemia" post="and coagulopathy, and intravenous acyclovir for severe VZV infection."/>
 <result pre="admission because of comatose consciousness (E2M2V1), dyspnea, and profound shock." exact="Brain" post="CT was not done due to unstable hemodynamic status"/>
 <result pre="CT scan room. Lumbar puncture was not considered due to" exact="coagulopathy" post="and absence of meningeal sign. However, lactate acidosis, disseminated"/>
 <result pre="room. Lumbar puncture was not considered due to coagulopathy and" exact="absence of" post="meningeal sign. However, lactate acidosis, disseminated intravascular coagulopathy and"/>
 <result pre="and absence of meningeal sign. However, lactate acidosis, disseminated intravascular" exact="coagulopathy" post="and multiple organ failure were not reversed by aggressive"/>
 <result pre="over trunk. B: Multinucleated giant cell on Tzank smear. Discussion" exact="Varicella" post="zoster is a highly contagious virus, which is transmitted"/>
 <result pre="trunk. B: Multinucleated giant cell on Tzank smear. Discussion Varicella" exact="zoster" post="is a highly contagious virus, which is transmitted dominantly"/>
 <result pre="contagious virus, which is transmitted dominantly by air droplet. Fatal" exact="varicella" post="zoster infection in immunocompromised patients has been reported [4,5]."/>
 <result pre="virus, which is transmitted dominantly by air droplet. Fatal varicella" exact="zoster" post="infection in immunocompromised patients has been reported [4,5]. Early"/>
 <result pre="which is transmitted dominantly by air droplet. Fatal varicella zoster" exact="infection" post="in immunocompromised patients has been reported [4,5]. Early administration"/>
 <result pre="Early administration of intravenous antiviral therapy is associated with better" exact="disease" post="resolution and may prevent VZV dissemination [6]. Post exposure"/>
 <result pre="and may prevent VZV dissemination [6]. Post exposure live attenuated" exact="varicella" post="vaccination is recommended for the healthy persons; in contrast,"/>
 <result pre="by current guideline because of risk of live vaccine related" exact="infection" post="in immunocompromised hosts [7]. Varicella-zoster immune globulin with passive"/>
 <result pre="in blood sample may contribute to early diagnosis of disseminated" exact="infection" post="of VZV before skin vesicular rash eruption in immunocompromised"/>
 <result pre="indicating the minimal inhibitory concentration of acyclovir treatment for disseminated" exact="varicella" post="infection in immunocompromised patients, the drug plasma concentration after"/>
 <result pre="the minimal inhibitory concentration of acyclovir treatment for disseminated varicella" exact="infection" post="in immunocompromised patients, the drug plasma concentration after intravenous"/>
 <result pre="400 mg) and is documented as the standard treatment of serious" exact="infection" post="in immunocompromised hosts [9]. The administration of oral famciclovir"/>
 <result pre="administration of oral famciclovir treatment in immunocompromised patients with disseminated" exact="cutaneous" post="and visceral involvement is not the standard of care."/>
 <result pre="the standard of care. In the present patient, he had" exact="chicken pox" post="after recent contact with diseased patients and oral famciclovir"/>
 <result pre="diseased patients and oral famciclovir was prescribed incorrectly for disseminated" exact="infection" post="in immunocompromised host on his first visit of the"/>
 <result pre="case report described a fulminant clinical course of severe VZV" exact="infection" post="in an immunocompromised patient. Early diagnosis, studies for possible"/>
 <result pre="and prompt antiviral therapy are needed for management of VZV" exact="infection" post="in immunocompromised patients. Author statement Manuscript: A Fatal Case"/>
 <result pre="in immunocompromised patients. Author statement Manuscript: A Fatal Case of" exact="Severe" post="Systemic Varicella Zoster Infection in a Patient with Chronic"/>
 <result pre="immunocompromised patients. Author statement Manuscript: A Fatal Case of Severe" exact="Systemic" post="Varicella Zoster Infection in a Patient with Chronic Use"/>
 <result pre="patients. Author statement Manuscript: A Fatal Case of Severe Systemic" exact="Varicella" post="Zoster Infection in a Patient with Chronic Use of"/>
 <result pre="Author statement Manuscript: A Fatal Case of Severe Systemic Varicella" exact="Zoster" post="Infection in a Patient with Chronic Use of Immunosuppressive"/>
 <result pre="statement Manuscript: A Fatal Case of Severe Systemic Varicella Zoster" exact="Infection" post="in a Patient with Chronic Use of Immunosuppressive Agents"/>
 <result pre="of Severe Systemic Varicella Zoster Infection in a Patient with" exact="Chronic" post="Use of Immunosuppressive Agents for Cutaneous Vasculitis. Authorship Responsibility"/>
 <result pre="in a Patient with Chronic Use of Immunosuppressive Agents for" exact="Cutaneous" post="Vasculitis. Authorship Responsibility All authors have seen and approved"/>
 <result pre="guidelines. References References 1HudsonM.BernatskyS.SuissaS.Anti-rheumatic drug use and risk of serious" exact="infections" post="in rheumatoid arthritisRheumatology46720071157116017478469 2TunbridgeA.J.BreuerJ.JefferyK.J.Chickenpox in adults - clinical managementJ"/>
 <result pre="adults - clinical managementJ Infect57220089510218555533 3DworkinR.H.Recommendations for the management of" exact="herpes" post="zosterClin Infect Dis44Supplement_12007S1S2617143845 4HabukaM.Fatal visceral disseminated varicella zoster infection"/>
 <result pre="the management of herpes zosterClin Infect Dis44Supplement_12007S1S2617143845 4HabukaM.Fatal visceral disseminated" exact="varicella" post="zoster infection during initial remission induction therapy in a"/>
 <result pre="management of herpes zosterClin Infect Dis44Supplement_12007S1S2617143845 4HabukaM.Fatal visceral disseminated varicella" exact="zoster" post="infection during initial remission induction therapy in a patient"/>
 <result pre="of herpes zosterClin Infect Dis44Supplement_12007S1S2617143845 4HabukaM.Fatal visceral disseminated varicella zoster" exact="infection" post="during initial remission induction therapy in a patient with"/>
 <result pre="infection during initial remission induction therapy in a patient with" exact="lupus" post="nephritis and rheumatoid arthritis-possible association with mycophenolate mofetil and"/>
 <result pre="during initial remission induction therapy in a patient with lupus" exact="nephritis" post="and rheumatoid arthritis-possible association with mycophenolate mofetil and high-dose"/>
 <result pre="therapy: a case reportBMC Res Notes111201816529506558 5FujisatoS.A fatal case of" exact="atypical" post="disseminated herpes zoster in a patient with meningoencephalitis and"/>
 <result pre="case reportBMC Res Notes111201816529506558 5FujisatoS.A fatal case of atypical disseminated" exact="herpes zoster" post="in a patient with meningoencephalitis and seizures associated with"/>
 <result pre="reportBMC Res Notes111201816529506558 5FujisatoS.A fatal case of atypical disseminated herpes" exact="zoster" post="in a patient with meningoencephalitis and seizures associated with"/>
 <result pre="case of atypical disseminated herpes zoster in a patient with" exact="meningoencephalitis" post="and seizures associated with steroid immunosuppressionAm J Case Rep1920181162116730270342"/>
 <result pre="of atypical disseminated herpes zoster in a patient with meningoencephalitis" exact="and seizures" post="associated with steroid immunosuppressionAm J Case Rep1920181162116730270342 6SheppD.H.DandlikerP.S.MeyersJ.D.Treatment of"/>
 <result pre="atypical disseminated herpes zoster in a patient with meningoencephalitis and" exact="seizures" post="associated with steroid immunosuppressionAm J Case Rep1920181162116730270342 6SheppD.H.DandlikerP.S.MeyersJ.D.Treatment of"/>
 <result pre="associated with steroid immunosuppressionAm J Case Rep1920181162116730270342 6SheppD.H.DandlikerP.S.MeyersJ.D.Treatment of varicella–Zoster" exact="virus infection" post="in severely immunocompromised patientsN Engl J Med314419862082123001523 7MarinM.Prevention of"/>
 <result pre="with steroid immunosuppressionAm J Case Rep1920181162116730270342 6SheppD.H.DandlikerP.S.MeyersJ.D.Treatment of varicella–Zoster virus" exact="infection" post="in severely immunocompromised patientsN Engl J Med314419862082123001523 7MarinM.Prevention of"/>
 <result pre="Immunization Practices (ACIP)MMWR Recomm Rep56Rr-42007140 8de JongM.D.Molecular diagnosis of visceral" exact="herpes" post="zosterLancet357927420012101210211445106 9de MirandaP.BlumM.R.Pharmacokinetics of acyclovir after intravenous and oral"/>
</results>
